Safety、Immunogenicity
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants (NCT05189548) | Changchun BCHT Biotechnology Co. | 2021-12-10 |
| Safety and Immunogenicity of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans (NCT02288286) | Beijing Center for Disease Control and Prevention | 2014-11-01 |
Track Safety、Immunogenicity automatically
Every clearance here is in the API, with alerts when new ones post.